{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:59:58Z","timestamp":1790877598291,"version":"4.1.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Next-generation sequencing (NGS) panels are increasingly used for the diagnosis of monogenic systemic autoinflammatory diseases (SAIDs). However, their role in patients with adult-onset Still\u2019s disease (AOSD) remains unknown. This study aims to assess the usefulness of NGS panels in AOSD patients to improve diagnosis and management of the disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This observational, multicenter study included all patients with AOSD diagnosis who underwent NGS panel testing in northern Spain. Clinical manifestations, laboratory parameters, complications, and therapeutic responses were recorded.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 24 patients (16 men, 8 women) with an average age of 42.2 \u00b1 17.9 (mean \u00b1 SD) years, in whom NGS was performed, fulfilled the Yamaguchi and\/or Fautrel criteria for AOSD. The most common symptoms, apart from fever, were skin rash (75%), asthenia (91.7%), and articular manifestations (91.7%). All patients had elevated acute-phase reactant levels and hyperferritinemia. Almost all patients received oral glucocorticoids as initial therapy. Conventional disease-modifying antirheumatic drugs (cDMARDs) were used in 17 (70.8%) patients and biologic therapy in 13 (54.1%) patients. Genetic variants were observed in 5 (20.8%) patients. None of them were classified as pathogenic. Variants of uncertain significance (VUS) were identified in <jats:italic>NOD2<\/jats:italic> (c.2104C&amp;gt;T and c.2251G&amp;gt;A), <jats:italic>TNFRSF1A<\/jats:italic> (c.224C&amp;gt;T), <jats:italic>TNFAIP3<\/jats:italic> (c.1939A&amp;gt;C), and <jats:italic>SCN9A<\/jats:italic> (c.2617G&amp;gt;A). Atypical manifestations and\/or therapeutic refractoriness were observed in patients carrying genetic variants, except for one patient with the <jats:italic>TNFAIP3<\/jats:italic> VUS. Four out of five patients with VUS had a severe and refractory course of the disease and required biologic therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>NGS was useful to rule out the presence of pathogenic genetic variants related to other SAIDs and to detect VUS that may help identify patients at risk for atypical and severe manifestations and poor response to conventional therapy.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1474271","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T11:46:41Z","timestamp":1731584801000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Molecular genetics in adult-onset Still\u2019s disease: next-generation sequencing in 24 patients and literature review"],"prefix":"10.3389","volume":"15","author":[{"given":"Diana","family":"Prieto-Pe\u00f1a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eztizen","family":"Labrador-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael B.","family":"Melero-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Ant\u00f3n-Pag\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Palmou-Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Alvarez-Reguera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerea","family":"Paz-Gandiaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jaut.2018.07.018","article-title":"A comprehensive review on adult onset Still\u2019s disease","volume":"93","author":"Giacomelli","year":"2018","journal-title":"J Autoimmun"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.058","article-title":"Adult-onset still\u2019s disease","volume":"13","author":"Gerfaud-Valentin","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2021.06.004","article-title":"Adult-onset Still\u2019s disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies","volume":"51","author":"Efthimiou","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"B4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3109\/07853890.2014.971052","article-title":"Adult-onset Still\u2019s disease-pathogenesis, clinical manifestations, and new treatment options","volume":"47","author":"Kadavath","year":"2015","journal-title":"Ann Med"},{"key":"B5","article-title":"MEFV gene mutations and their clinical significance in Korean patients with adult-onset Still\u2019s disease","volume":"31","author":"Kim","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-012-2609-8","article-title":"The association of TNFRSF1A gene and MEFV gene mutations with adult onset Still\u2019s disease","volume":"33","author":"Cosan","year":"2013","journal-title":"Rheumatol Int"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.131563","article-title":"CIAS1 and NOD2 genes in adult-onset Still\u2019s disease","volume":"41","author":"Garcia-Melchor","year":"2014","journal-title":"J Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12463","article-title":"Increased prevalence of MEFV exon 10 variants in Japanese patients with adult-onset Still\u2019s disease","volume":"179","author":"Nonaka","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-017-3885-0","article-title":"Evidence for genetic overlap between adult onset Still\u2019s disease and hereditary periodic fever syndromes","volume":"38","author":"Sighart","year":"2018","journal-title":"Rheumatol Int"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780290316","article-title":"Adult-onset still\u2019s disease","volume":"29","author":"Wouters","year":"1986","journal-title":"Dis course HLA associations Arthritis Rheum"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102562","article-title":"The amino acid variants in HLA II molecules explain the major association with adult-onset Still\u2019s disease in the Han Chinese population","volume":"116","author":"Teng","year":"2021","journal-title":"J Autoimmun"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780241203","article-title":"HLA-Bw35 and prognosis in adult Still\u2019s disease","volume":"24","author":"Terkeltaub","year":"1981","journal-title":"Arthritis Rheum"},{"key":"B13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s13075-017-1406-x","article-title":"Effects of HLA-DRB1 alleles on susceptibility and clinical manifestations in Japanese patients with adult onset Still\u2019s disease","volume":"19","author":"Asano","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S343261","article-title":"Improving diagnosis and clinical management of acquired systemic autoinflammatory diseases","volume":"15","author":"Al-Hakim","year":"2022","journal-title":"J Inflammation Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez294","article-title":"Current and future advances in genetic testing in systemic autoinflammatory diseases","volume":"58","author":"Schnappauf","year":"2019","journal-title":"Rheumatol (Oxford)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126360","article-title":"Monogenic autoinflammatory diseases: state of the art and future perspectives","volume":"22","author":"Di Donato","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-201271","article-title":"Guidelines for the genetic diagnosis of hereditary recurrent fevers","volume":"71","author":"Shinar","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-019-0439-9","article-title":"Current practices for the genetic diagnosis of autoinflammatory diseases: results of a European Molecular Genetics Quality Network Survey","volume":"27","author":"Rowczenio","year":"2019","journal-title":"Eur J Hum Genet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvaa024","article-title":"ISSAID\/EMQN best practice guidelines for the genetic diagnosis of monogenic autoinflammatory diseases in the next-generation sequencing era","volume":"66","author":"Shinar","year":"2020","journal-title":"Clin Chem"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.130325","article-title":"A patient with a phenotype of adult-onset still disease, but a genotype typical of cryopyrin-associated periodic fever syndrome","volume":"40","author":"Eriksson","year":"2013","journal-title":"J Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000629","article-title":"An adult patient with a novel mutation in NLRP3 gene associated with cryopyrin-associated periodic syndrome mimicking adult-onset still disease","volume":"24","author":"Ocampo","year":"2018","journal-title":"J Clin Rheumatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4178-z","article-title":"Molecular genetic analysis for periodic fever syndromes: a supplemental role for the diagnosis of adult-onset Still\u2019s disease","volume":"37","author":"Li","year":"2018","journal-title":"Clin Rheumatol"},{"key":"B23","article-title":"Preliminary criteria for classification of adult Still\u2019s disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/00005792-200205000-00003","article-title":"Proposal for a new set of classification criteria for adult-onset still disease","volume":"81","author":"Fautrel","year":"2002","journal-title":"Med (Baltimore)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2022.08.020","article-title":"Genetic testing in autoinflammatory diseases - past, current and future perspectives","volume":"106","author":"Le Goueff","year":"2022","journal-title":"Eur J Intern Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa904","article-title":"Dissecting the clinical heterogeneity of adult-onset Still\u2019s disease: results from a multi-dimensional characterization and stratification","volume":"60","author":"Berardicurti","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003419","article-title":"Derivation and validation of four patient clusters in Still\u2019s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry","volume":"9","author":"Ruscitti","year":"2023","journal-title":"RMD Open"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac439","article-title":"AOSD endotypes based on immune cell profiles: patient stratification with hierarchical clustering analysis","volume":"62","author":"Guo","year":"2023","journal-title":"Rheumatol (Oxford)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1474271\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T11:46:45Z","timestamp":1731584805000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1474271\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":29,"alternative-id":["10.3389\/fimmu.2024.1474271"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1474271","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]},"article-number":"1474271"}}